Market Overview

Medtronic Narrows FY13 EPS Outlook

Related MDT
St. Jude Medical Hits New Lifetime High - Analyst Blog
Deutsche Bank Reiterates On Medtronic And Covidien Amid Acquisition Proposal
In Pursuit of Shire, AbbVie Eyes Lower Taxes in UK (Fox Business)

In a presentation to investors, Medtronic, Inc. (NYSE: MDT) today updated diluted earnings per share (EPS) guidance for fiscal year 2013.

The Company tightened its fiscal 2013 diluted EPS guidance range to $3.66 to $3.70 from the previously stated range of $3.62 to $3.70. The new range implies annual EPS growth of 6 to 7%.

Posted-In: News Guidance


Most Popular

Related Articles (MDT)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free